Brind.

SCWorx Corp. Resumes Trading on Nasdaq Following Regulatory Approval

1 report, 1 independent Updated Oct 1
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

SCWorx Corp. resumed trading on the Nasdaq Capital Market on October 1, 2026, after filing a Form 8-K with the Securities and Exchange Commission. The Nasdaq Hearings Panel had previously granted SCWorx's request to reconsider a delisting decision. The Panel subsequently determined that the company had regained compliance with Nasdaq's listing requirements and approved its continued listing, subject to a one-year Panel Monitor.

From manilatimes.net

Why it matters

Some supportBrind's analysis of the reports

SCWorx highlighted improved operating performance, including better gross profitability and cash utilization, during the first half of 2026. The company also noted expanding healthcare customer relationships and continued investment in its proprietary healthcare data and technology platform.

From manilatimes.net

Who's involved

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped